In addition, it addresses the FDA’s communications Using the applicant, the retention of data that assist the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer ownership of the SE report back to a new applicant and electronic submission in the SE report and amendmen